ReAct Africa Supports Iraq in Advancing Its AMR National Action Plan (NAP) 2.0
The WHO Iraq Country Office and the Ministry of Health, Iraq, with technical support from ReAct Africa and WHO EMRO, organized a multi-stakeholder workshop to support the update of Iraq’s NAP on AMR. The workshop brought together key stakeholders—including the Ministry of Agriculture, Ministry of Environment, academia, civil society, and international partners to discuss, prioritize, and finalize activities for implementation during 2026–2030, including the M&E framework.
The workshop resulted in a structured roadmap for finalizing AMR NAP 2.0 for Iraq.
ReAct Africa provided technical support to the Ministry of Health, Iraq, in drafting and preparing the first version of the updated AMR NAP 2.0, which was shared in advance and served as the basis for discussions.
Held from 25–27 February 2025 in Baghdad, the workshop included interactive sessions aligned with the five strategic objectives of the Global Action Plan on AMR. ReAct Africa conducted prioritization exercises with stakeholders to identify key national priorities and worked collaboratively to refine activities and align them with realistic timelines, responsibilities, and implementation pathways. In addition, ReAct Africa, in collaboration with WHO EMRO, developed the Monitoring and Evaluation (M&E) plan and facilitated in-depth discussions on its components during the workshop. This included defining indicators, setting measurable targets, and identifying mechanisms for tracking progress and accountability.
ReAct’s facilitation supported consensus-building, strengthened cross-sectoral alignment, and ensured that the updated NAP is both actionable and measurable. This initiative is part of ReAct Africa’s broader commitment to supporting countries in the Global South in translating global AMR commitments into practical, country-led actions. Through strategic guidance and technical collaboration, ReAct Africa continues to empower countries like Iraq to build sustainable and context-appropriate responses to antimicrobial resistance.